Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy

There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of TNFα inhibitors due to active tuberculosis (TB). We evaluated the safety of restarting anti-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Suh, Young Sun, Kwok, Seung-ki, Ju, Ji Hyeon, Park, Kyung-Su, Park, Sung-Hwan, Yoon, Chong-Hyeon
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890474/
https://ncbi.nlm.nih.gov/pubmed/24431903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2014.29.1.38
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars